BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 8336938)

  • 1. In vivo tumorigenicity and in vitro sensitivity to tumor-necrosis-factor alpha mediated killing of c-Ha-ras-transformed cells.
    Gonen B; Kahana O; Witz IP
    Cancer Immunol Immunother; 1992; 35(6):388-94. PubMed ID: 1327528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation.
    Danial NN; Losman JA; Lu T; Yip N; Krishnan K; Krolewski J; Goff SP; Wang JY; Rothman PB
    Mol Cell Biol; 1998 Nov; 18(11):6795-804. PubMed ID: 9774693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic transforming potential of activated ras in chimeric mice.
    Hawley RG; Fong AZ; Ngan BY; Hawley TS
    Oncogene; 1995 Sep; 11(6):1113-23. PubMed ID: 7566971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V-Ha-ras-dependent expression of interleukin-3 mRNA in premalignant PB-3c mast cells correlates with the formation of tumors without interleukin-3 gene rearrangements.
    Aebersold DM; Banholzer R; Backenstoss V; Hirsch HH; Moroni C
    Exp Hematol; 1997 May; 25(5):395-404. PubMed ID: 9168061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage-specific transformation of murine B lineage cells by ras and myc.
    Overell RW; Weisser KE; Hess B; Namen AE; Grabstein KH
    Oncogene; 1989 Dec; 4(12):1425-32. PubMed ID: 2687765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-promoting phorbol ester and activated Ha-ras synergistically reduce the interleukin 3 requirement in a mast cell line.
    Imber R; Fabbro D
    Cancer Res; 1991 Jan; 51(2):632-8. PubMed ID: 1985780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of IL-7 and v-Ha-ras in the in vitro neoplastic progression of murine pre-B cells.
    Chen SC; Redenius D; Young JC; Schwartz RC
    Oncogene; 1993 Aug; 8(8):2119-25. PubMed ID: 8336938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New members of the interleukin family: interleukins 6 and 7].
    Berezowicz PS
    Postepy Hig Med Dosw; 1991; 45(6):405-17. PubMed ID: 1813882
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.